Valuation: Bionime Corporation

Market Cap 4.51B 139M 122M 114M 105M 196M 13.32B 201M 1.35B 529M 6.59B 522M 511M 22.78B P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 7.08B 218M 192M 179M 164M 308M 20.93B 315M 2.12B 831M 10.36B 820M 802M 35.8B EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 day+1.39%
1 week+4.48%
Current month+4.86%
1 month+2.28%
3 months-7.46%
6 months+5.42%
Current year-2.02%
1 week 54.8
Extreme 54.8
58.6
1 month 54.8
Extreme 54.8
69.9
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 09/07/2010
Director of Finance/CFO - 06/11/2017
Chief Tech/Sci/R&D Officer - 07/11/2018
Director TitleAgeSince
Chairman - 14/04/2003
Director/Board Member - 17/10/2007
Director/Board Member - 15/05/2007
Change 5-day change 1-year change 3-year change Capi.($)
+1.39%+4.48%-13.81%-14.28% 137M
+2.07%-2.32%+239.91%+277.37% 19.04B
-2.80%+4.29%-42.18%-25.33% 10.07B
-2.37%-3.18%+40.28%+17.10% 6.68B
-0.01%+1.63%+241.54%-24.08% 5.97B
+0.31%+4.14%-15.57%-20.65% 5.53B
-0.55%+1.24%-43.42% - 4.41B
+0.34%+5.76%-21.14%-30.56% 4.26B
-0.33%-16.23%+70.56%+88.36% 4.15B
+2.54%+0.15%-18.58%-43.19% 2.69B
Average +0.16%-0.25%+43.76%+24.97% 6.3B
Weighted average by Cap. +0.20%-1.47%+91.00%+85.42%

Financials

2024 2025
Net sales 1.93B 59.68M 52.44M 48.95M 44.92M 84.09M 5.72B 86.16M 580M 227M 2.83B 224M 219M 9.78B 1.84B 56.74M 49.86M 46.54M 42.71M 79.95M 5.43B 81.92M 552M 216M 2.69B 213M 208M 9.3B
Net income -127M -3.93M -3.45M -3.22M -2.96M -5.53M -376M -5.67M -38.18M -14.93M -186M -14.74M -14.42M -643M -180M -5.56M -4.89M -4.56M -4.19M -7.84M -533M -8.03M -54.11M -21.16M -264M -20.89M -20.43M -912M
Net Debt 2.78B 85.92M 75.49M 70.47M 64.67M 121M 8.23B 124M 836M 327M 4.07B 323M 316M 14.08B 2.57B 79.42M 69.79M 65.14M 59.79M 112M 7.61B 115M 772M 302M 3.76B 298M 292M 13.01B
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
29/07/26 NT$58.30 +1.39% 146,565
28/07/26 NT$57.50 +0.35% 90,832
27/07/26 NT$57.30 +1.60% 56,316
24/07/26 NT$56.40 +1.81% 54,016
23/07/26 NT$55.40 -1.60% 66,098

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock